Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 24 peer-reviewed journal articles Updated
Pediatric Neurology · Autosomal Recessive Cerebellar Ataxia-Epilepsy-Intellectual Disability Syndrome

Understanding Your Child's Diagnosis: Cerebellar Ataxia, Epilepsy, and Intellectual Disability Syndrome

At a Glance

This rare inherited diagnosis describes a group of conditions involving seizures, balance and coordination problems, and intellectual or developmental disability. Genetic testing can identify the specific subtype and help guide monitoring, therapies, and support for the whole family.

Receiving a diagnosis like Autosomal Recessive Cerebellar Ataxia-Epilepsy-Intellectual Disability Syndrome can feel overwhelming. It is a long, complex name for a rare condition that affects how a child’s brain and body develop [1]. Because this name describes a “triad” of symptoms rather than a single specific gene, doctors may use it as an umbrella term while they work to identify the exact genetic cause [2][3].

Understanding this diagnosis is a journey of translating medical labels into a roadmap for your child’s care.

Decoding the Name

This condition is named after the three primary ways it affects a child:

  • Autosomal Recessive: This describes how the condition is inherited. It means a child inherited two changed copies of a specific gene—one from each parent [4][5]. Typically, the parents are “carriers” who do not have the condition themselves.
  • Cerebellar Ataxia: This refers to challenges with balance, coordination, and fine motor skills. It is caused by changes in the cerebellum (the part of the brain that controls movement) [6][7].
  • Epilepsy: This means the child has a tendency to have repeated seizures. In many cases of this syndrome, seizures begin in early infancy and may be difficult to control with standard medications [8][9].
  • Intellectual Disability: This describes impairments in both intellectual and adaptive functioning. In very young children, clinicians may use the term global developmental delay while assessments continue [6][10].

The Role of Specific Genes

While the name describes the symptoms, the underlying cause is always a change in a specific gene. You may see references to specific SCAR (Spinocerebellar Ataxia Recessive) numbers. These are distinct genetic disorders that share this broad clinical presentation, and knowing which one your child has is vital for their care. These ranges of severity are variable rather than typical paths for every child:

  • SCAR23 (TDP2 Gene): This subtype is caused by changes in the TDP2 gene, which helps repair DNA. It often involves childhood-onset balance issues and drug-resistant seizures [1][11].
  • SCAR12 (WWOX Gene): This version is linked to the WWOX gene. It typically presents as a severe form of epilepsy in infancy along with significant developmental delays [3][12].
  • SCAR17 (CWF19L1 Gene): This subtype may begin with developmental delays and seizures in early childhood, with balance and movement issues (ataxia) appearing more clearly during the teenage years [7].
  • TBC1D24-Related Disorders: Sometimes grouped with these syndromes, changes in the TBC1D24 gene can cause a wide spectrum of symptoms, ranging from mild epilepsy to more complex conditions like DOORS syndrome, which also affects hearing and physical development [4][8].

Navigating the Emotional Impact

Finding out your child has a rare genetic condition is a profound emotional event. It is common to experience a “diagnostic odyssey”—a long period of searching for answers—followed by a mix of relief and intense grief once the answer arrives [13][14].

Common Emotional Responses

  • Uncertainty: Even with a diagnosis, the rarity of these conditions means that “what comes next” isn’t always clear. This uncertainty can be a major source of ongoing stress for parents [15].
  • Caregiver Burden: Managing multiple appointments, medications, and therapies is exhausting. Studies show that a high percentage of rare-disease caregivers experience clinically significant levels of anxiety and distress [16][17].
  • Isolation: Because few people have heard of these specific syndromes, you may feel like others don’t understand your daily reality [18].

Finding a Way Forward

While the diagnosis is permanent, your family’s ability to cope can be strengthened.

  • Seek Specialized Support: Programs focused on “psychological flexibility” and Cognitive Behavioral Therapy (CBT) have been shown to help parents of children with rare diseases reduce stress and improve their overall well-being [19][20].
  • Connect with Peers: Joining rare-disease communities can provide “lived experience” knowledge that even doctors may not have. These groups offer emotional connection and practical tips for daily life [21][22].
  • Focus on the “Whole Child”: While the genetic label is important for medical management, your child is more than their diagnosis. Early intervention—including physical, occupational, and speech therapy—is essential to help them reach their individual potential [23][24].

Common questions in this guide

What does this long diagnosis mean for my child?
It describes a group of rare inherited conditions that can affect balance and coordination, cause seizures, and affect intellectual or developmental skills. Doctors may use it as an umbrella diagnosis while genetic testing looks for the specific cause.
How is this condition passed down in families?
It follows an autosomal recessive pattern, meaning a child inherits two changed copies of a gene, one from each parent. Parents are often carriers and do not have symptoms themselves.
Why is identifying the specific gene important?
Related genetic subtypes can differ in when seizures, developmental concerns, or ataxia begin and how severe they are. Knowing the gene can help the care team tailor monitoring, treatment, and counseling for the family.
What symptoms might my child experience?
Possible features include seizures, balance and coordination problems, fine-motor difficulties, and intellectual disability or global developmental delay. Seizures may start in infancy and can be difficult to control in some subtypes, while timing and severity vary.
What therapies can help my child develop skills?
Early intervention with physical, occupational, and speech therapy can support movement, daily skills, communication, and your child's individual potential. These therapies complement, but do not replace, care from specialists managing seizures and the underlying genetic condition.
How can parents cope with the emotional and practical strain?
Parents may benefit from a genetic counselor, rare-disease peer communities, and mental health support such as cognitive behavioral therapy. Practical help with appointments, medicines, and therapies can also reduce caregiver strain and isolation.
What should we monitor between specialist visits?
Ask the care team which changes to track, such as seizure frequency, movement and balance, development, or hearing when relevant to the child's subtype. Monitoring plans should be individualized because related genetic conditions can affect children differently.

Get notified when new evidence is published on Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to TUD deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (24)
  1. 1

    A novel pathogenic variant in TDP2 causes spinocerebellar ataxia autosomal recessive 23 accompanied by pituitary tumor and hyperhidrosis: a case report.

    Zheng Y, She Y, Su Z, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2024; (45(6)):2881-2885 doi:10.1007/s10072-024-07397-9.

    PMID: 38433132
  2. 2

    Consolidating the Role of TDP2 Mutations in Recessive Spinocerebellar Ataxia Associated with Pediatric Onset Drug Resistant Epilepsy and Intellectual Disability (SCAR23).

    Ciaccio C, Castello R, Esposito S, et al.

    Cerebellum (London, England) 2019; (18(5)):972-975 doi:10.1007/s12311-019-01069-7.

    PMID: 31410782
  3. 3

    WWOX P47T partial loss-of-function mutation induces epilepsy, progressive neuroinflammation, and cerebellar degeneration in mice phenocopying human SCAR12.

    Hussain T, Sanchez K, Crayton J, et al.

    Progress in neurobiology 2023; (223()):102425 doi:10.1016/j.pneurobio.2023.102425.

    PMID: 36828035
  4. 4

    Alternating Hemiplegia and Epilepsia Partialis Continua: A new phenotype for a novel compound TBC1D24 mutation.

    Ragona F, Castellotti B, Salis B, et al.

    Seizure 2017; (47()):71-73 doi:10.1016/j.seizure.2017.03.003.

    PMID: 28292732
  5. 5

    A case of early-onset epileptic encephalopathy with a homozygous TBC1D24 variant caused by uniparental isodisomy.

    Nakashima M, Negishi Y, Hori I, et al.

    American journal of medical genetics. Part A 2019; (179(4)):645-649 doi:10.1002/ajmg.a.61056.

    PMID: 30680869
  6. 6

    Clinical trajectories and medication response in TBC1D24-related epilepsies.

    Mondragon E, Magielski JH, Bane B, et al.

    Epilepsia 2026; (67(3)):1386-1397 doi:10.1111/epi.70013.

    PMID: 41215607
  7. 7

    Expansion of the phenotypic and molecular spectrum of CWF19L1-related disorder.

    Alvarez C, Grimmel M, Ebrahimi-Fakhari D, et al.

    Clinical genetics 2023; (103(5)):566-573 doi:10.1111/cge.14275.

    PMID: 36453471
  8. 8

    TBC1D24 genotype-phenotype correlation: Epilepsies and other neurologic features.

    Balestrini S, Milh M, Castiglioni C, et al.

    Neurology 2016; (87(1)):77-85 doi:10.1212/WNL.0000000000002807.

    PMID: 27281533
  9. 9

    Infantile epilepsy with multifocal myoclonus caused by TBC1D24 mutations.

    Zhang J, Chen J, Zeng Q, et al.

    Seizure 2019; (69()):228-234 doi:10.1016/j.seizure.2019.05.010.

    PMID: 31112829
  10. 10

    [Clinical phenotypes of TBC1D24 gene related epilepsy].

    Zhang J, Zhang YH, Chen JY, et al.

    Zhonghua er ke za zhi = Chinese journal of pediatrics 2018; (56(9)):667-673 doi:10.3760/cma.j.issn.0578-1310.2018.09.007.

    PMID: 30180405
  11. 11

    Confirming TDP2 mutation in spinocerebellar ataxia autosomal recessive 23 (SCAR23).

    Zagnoli-Vieira G, Bruni F, Thompson K, et al.

    Neurology. Genetics 2018; (4(4)):e262 doi:10.1212/NXG.0000000000000262.

    PMID: 30109272
  12. 12

    WWOX Loss of Function in Neurodevelopmental and Neurodegenerative Disorders.

    Aldaz CM, Hussain T

    International journal of molecular sciences 2020; (21(23)) doi:10.3390/ijms21238922.

    PMID: 33255508
  13. 13

    Waiting for a diagnosis in Rubinstein-Taybi: The journey from "ignorance is bliss" to the value of "a label".

    Withers CM, Fleming J, Wallingford CK, et al.

    American journal of medical genetics. Part A 2021; (185(1)):105-111 doi:10.1002/ajmg.a.61920.

    PMID: 33063426
  14. 14

    Evaluation of the parents' anxiety levels before and after the diagnosis of their child with a rare genetic disease: the necessity of psychological support.

    Kolemen AB, Akyuz E, Toprak A, et al.

    Orphanet journal of rare diseases 2021; (16(1)):402 doi:10.1186/s13023-021-02046-2.

    PMID: 34583726
  15. 15

    Cognitive and emotional experiences of parents of children with Tyrosine Hydroxylase Deficiency during the diagnostic journey in Serbia: A preliminary study.

    Krstić T, Milankov V, Golubović Š

    Journal of genetic counseling 2026; (35(3)):e70231 doi:10.1002/jgc4.70231.

    PMID: 42141694
  16. 16

    Assessing Psychological Harms on Parents and Primary Caregivers of Children Living with a Rare Disease: A Systematic Review of the Scope and Validity of Surveys Utilized.

    Bull LJ, Eslick GD, Teutsch SM, Elliott EJ

    Clinical child and family psychology review 2025; (28(3)):612-630 doi:10.1007/s10567-025-00533-7.

    PMID: 40588644
  17. 17

    Psychosocial Functioning in Parents of MPS III Patients.

    Conijn T, Nijmeijer SCM, van Oers HA, et al.

    JIMD reports 2019; (44()):33-41 doi:10.1007/8904_2018_119.

    PMID: 29980992
  18. 18

    Emotional experiences of family caregivers of children with Dravet syndrome.

    Domaradzki J, Walkowiak D

    Epilepsy & behavior : E&B 2023; (142()):109193 doi:10.1016/j.yebeh.2023.109193.

    PMID: 37028149
  19. 19

    Cognitive-Based Interventions for Improving Psychological Health and Well-Being for Parents of Children with Developmental Disabilities: A Systematic Review and Meta-analysis.

    Li S, Yong Y, Li Y, et al.

    Journal of autism and developmental disorders 2024; (54(9)):3316-3335 doi:10.1007/s10803-023-06063-x.

    PMID: 37668850
  20. 20

    A web-based psychological support program for caregivers of children with rare chronic diseases: a randomized controlled trial.

    Tutus D, Niemitz M, Plener PL, et al.

    Orphanet journal of rare diseases 2024; (19(1)):27 doi:10.1186/s13023-024-03029-9.

    PMID: 38281056
  21. 21

    Common needs in uncommon conditions: a qualitative study to explore the need for care in pediatric patients with rare diseases.

    Smits RM, Vissers E, Te Pas R, et al.

    Orphanet journal of rare diseases 2022; (17(1)):153 doi:10.1186/s13023-022-02305-w.

    PMID: 35379257
  22. 22

    Alone in a Crowd? Parents of Children with Rare Diseases' Experiences of Navigating the Healthcare System.

    Baumbusch J, Mayer S, Sloan-Yip I

    Journal of genetic counseling 2018; doi:10.1007/s10897-018-0294-9.

    PMID: 30128673
  23. 23

    A 21-Year Diagnostic Odyssey in TBC1D24-Associated Developmental and Epileptic Encephalopathy With Favorable Response to Corpus Callosotomy: A Case Report.

    Pacheco-Abbud A, Pérez-Arzola AA, Martínez Torres AS, et al.

    Cureus 2026; (18(8)):e114608 doi:10.7759/cureus.114608.

    PMID: 42746598
  24. 24

    Developmental and epileptic encephalopathies: what we do and do not know.

    Specchio N, Curatolo P

    Brain : a journal of neurology 2021; (144(1)):32-43 doi:10.1093/brain/awaa371.

    PMID: 33279965

This page explains the broad cerebellar ataxia-epilepsy-intellectual disability diagnosis for informational purposes only and does not constitute medical advice. Your child's pediatric neurologist, genetics team, and therapists should interpret test results and create an individualized care plan.

Guide contents Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to TUD deficiency
Research & Literature
02 Symptoms and Clinical Progression